Manchester Capital Management’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-65,742
| Closed | -$1.33M | – | 1135 |
|
|
2021
Q3 | $1.33M | Hold |
65,742
| – | – | 0.18% | 77 |
|
|
2021
Q2 | $2.45M | Hold |
65,742
| – | – | 0.34% | 37 |
|
|
2021
Q1 | $1.68M | Hold |
65,742
| – | – | 0.25% | 57 |
|
|
2020
Q4 | $1.45M | Buy |
65,742
+7,285
| +12% | +$160K | 0.22% | 65 |
|
|
2020
Q3 | $1.05M | Buy |
58,457
+11,314
| +24% | +$204K | 0.16% | 79 |
|
|
2020
Q2 | $1.2M | Hold |
47,143
| – | – | 0.16% | 74 |
|
|
2020
Q1 | $866K | Hold |
47,143
| – | – | 0.14% | 89 |
|
|
2019
Q4 | $1.04M | Buy |
47,143
+28,286
| +150% | +$623K | 0.11% | 103 |
|
|
2019
Q3 | $271K | Hold |
18,857
| – | – | 0.03% | 212 |
|
|
2019
Q2 | $297K | Hold |
18,857
| – | – | 0.04% | 202 |
|
|
2019
Q1 | $276K | Hold |
18,857
| – | – | 0.04% | 201 |
|
|
2018
Q4 | $231K | Hold |
18,857
| – | – | 0.04% | 196 |
|
|
2018
Q3 | $288K | Hold |
18,857
| – | – | 0.04% | 189 |
|
|
2018
Q2 | $231K | Hold |
18,857
| – | – | 0.04% | 199 |
|
|
2018
Q1 | $180K | Buy |
+18,857
| New | +$180K | 0.03% | 212 |
|